An interventional study of Nursing Intervention Program and Usual Care in Coronary Artery Disease, Myocardial Revascularization and Postoperative Recovery After Cardiac Surgery, sponsored by Universidad de la Sabana. Not yet recruiting at 1 site in Colombia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-08.
Sponsored by Universidad de la Sabana · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Coronary Artery Disease with a site in Colombia — 2 open to participants now, 3 under way, 1 of them phase 3. Coronary Artery Disease · Colombia.
Among the 15 studies in Coronary Artery Disease with a site in Colombia, this one is the 9th largest by planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2027, is the only one with no phase, and was the 15th registered.
4,866 studies on the registry are indexed under Coronary Artery Disease; 892 are open to participants now.
Browse Coronary Artery Disease studies →2 of the 15 studies in Coronary Artery Disease with a site in Colombia are open now. Recruiting first, the newest first:
Medtronic · Sites in Colombia, United States, Argentina and 38 more countries
A study can be open while its sites in Colombia have not opened yet or have stopped. Only those recruiting at a site in Colombia →
Of the 591 Coronary Artery Disease studies recruiting now, 404 (68%) set no upper age limit and 68 (12%) stop at 75 or younger; 37 take children under 18; 49 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 6 · Phase 3 4
First in 2010; this study’s year is marked. 1 started in 2027.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 123 across 3,011 interventional studies indexed under Coronary Artery Disease.
Median enrollment 70 across the 11 interventional studies, 20,095 across the 4 observational. Of the 7 that completed or were terminated, 5 (71%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 15 have an industry lead sponsor. The 10 most frequent:
Universidad de la Sabana is the lead sponsor of 23 studies on the registry; 8 are open to participants now.
Universidad de la Sabana has 1 study filed under Coronary Artery Disease — fewer than ten, so there is no comparison to draw.
1 of the studies in Coronary Artery Disease with a site in Colombia that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07576569Universidad de la SabanaNursing Intervention for Adaptation After Myocardial Revascularization | 2027-08 |
Add it to your calendar (.ics) → With an account.
Among the 15 studies in Coronary Artery Disease with a site in Colombia, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Introduction: Myocardial revascularization is an essential procedure for patients with cardiovascular disease. Its recovery in the outpatient setting involves significant challenges for both the patient and the caregiver. This recovery phase may generate physical, emotional, and psychological complications that require an effective adaptation process of the patient-caregiver dyad to ensure successful recovery and improved quality of life.
Objective: To evaluate the preliminary effectiveness of a nursing intervention aimed at improving adaptation in the patient-caregiver dyad during the outpatient postoperative period following myocardial revascularization, compared with usual care, in Bucaramanga during the period 2026-2027.
Materials and Methods: A pilot randomized controlled trial will be conducted to develop and evaluate a novel nursing intervention aimed at promoting adaptation in patients undergoing outpatient postoperative myocardial revascularization and their caregivers. The intervention will be designed and its feasibility, acceptability, and preliminary effectiveness will be assessed. Data analysis will be performed using descriptive and inferential statistical methods, considering the distribution and behavior of the data.
Expected Results: The study is expected to assess the preliminary effectiveness of the proposed intervention through the integration of theoretical and empirical components.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive a structured nursing intervention based on the Roy Adaptation Model, including education, emotional support, and follow-up during the 30-day outpatient postoperative period following myocardial revascularization.
Behavioral: Nursing Intervention Program
Participants will receive standard postoperative care without the structured nursing intervention.
Other: Usual Care
Structured nursing intervention focused on improving adaptation in the patient-caregiver dyad through education, emotional support, and follow-up care.
Participants will receive standard postoperative care without the structured nursing intervention.
Adaptation level in the patient-caregiver dyad
Adaptation will be assessed using validated instruments that measure dimensions related to the Roy Adaptation Model, including physiological, self-concept, role function, and interdependence domains in both patient and caregiver.
Time frame: Baseline and 30 days post-discharge
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jan 2027; primary completion for Aug 2027, 7 months later.
Of 756 non-industry interventional studies with no phase under Coronary Artery Disease, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 53. This study's planned 7 months is below that.
Counting every sponsor, half of 933 studies reached it within 30 months; a quarter within 15 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad de la Sabana